Skip to content

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02823041
Acronym
CT&E-RCT
Enrollment
100
Registered
2016-07-06
Start date
2016-10-13
Completion date
2023-06-30
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder

Keywords

cognitive training, aerobic exercise, neurotrophic factors, randomized controlled trial, functional outcome

Brief summary

This is a confirmatory randomized controlled trial of the efficacy of a novel intervention combining neuroplasticity-based cognitive training with aerobic exercise, compared to the same systematic cognitive training alone. Treatment occurs for 6 months after randomization, with a followup assessment at 12 months. The investigators hypothesize that combining neuroplasticity-based computerized cognitive training and neurotrophin-enhancing physical exercise will produce neurotrophin increases and cognitive and functional improvements, even relative to cognitive training alone. The investigators target the period shortly after a first episode of schizophrenia to maximize the generalization of cognitive improvement to functional outcome, before chronic disability is established.

Detailed description

The Cognitive Training and Exercise intervention consists of 24 weeks of systematic computerized cognitive training, 4 hours per week, plus aerobic exercise, 150 minutes per week. The Cognitive Training Intervention includes the same systematic cognitive training. The first 12 weeks involve neurocognitive training, using training exercises from Posit Science Brain HQ. The second 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. Aerobic exercise occurs as two 45-minute sessions at the clinic and two 30-minute sessions at home weekly. Intensity of aerobic exercise is tailored to maintain an individualized target heart rate zone and is monitored by a heart rate recorder. A weekly one-hour Bridging Skills Group with other members of the treatment condition is designed to aid generalization of training to everyday life situations. The immediate target is brain-derived neurotrophic factor. The primary treatment outcomes are overall cognitive deficit level and global functioning level.

Interventions

BEHAVIORALCognitive Training

24 weeks of systematic computerized cognitive training, 4 hours per week. The first 12 weeks involves neurocognitive training, using auditory training exercises from Posit Science Brain HQ. The 2nd 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. A weekly one-hour Bridging Skills Group is designed to aid generalization of training to everyday life situations.

BEHAVIORALAerobic Exercise

Aerobic exercise occurs as two 45-minute sessions at the clinic and two 30-minute sessions at home weekly. Exercise involves an adaptation of interval training, including a variety of calisthenics that can be done without specialized equipment. Intensity of aerobic exercise is tailored to maintain an individualized target heart rate zone and is monitored by a heart rate recorder.

An individual therapist will provide weekly case management and therapy targeting the individual psychological problems and everyday functioning needs of the patient

An job/school specialist will use the Individual Placement and Support model to help participants return to school or work and provide ongoing outreach support.

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. a first episode of a psychotic illness that began within the past two years; 2. a diagnosis by DSM-5 of schizophrenia, schizoaffective disorder, mainly depressed type, or schizophreniform disorder; 3. sufficient acculturation and fluency in the English language to avoid invalidating research measures; and 4. residence likely to be within commuting distance of the UCLA Aftercare Research Program.

Exclusion criteria

1. inability to participate in aerobic exercise; 2. evidence of a known neurological disorder (e.g., epilepsy) or significant head injury; 3. evidence of moderate or severe alcohol or substance use disorder within the six months prior to the first episode or evidence that substance abuse triggered the psychotic episode or makes the schizophrenia diagnosis ambiguous; or 4. mental retardation, i.e. estimated premorbid IQ less than 70.

Design outcomes

Primary

MeasureTime frameDescription
Global Functioning Scale: mean of Role and Social ratings6 monthsA 10-point rating scale to evaluate role and social functioning
Brain-derived neurotrophic factor (BDNF)6 monthsBDNF is a key neurochemical factor known to mediate the effects of exercise in the brain
Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) overall composite score6 monthsThe Overall Composite score from the MCCB is a summary of cognitive performance across seven domains.

Secondary

MeasureTime frameDescription
YMCA fitness test6 monthsCardiorespiratory fitness and muscular endurance measured by the YMCA fitness test
VO2 Max6 monthsA cardiovascular fitness measure derived from a treadmill test protocol
Role Functioning Scale6 months7-point ratings of Work Productivity, Independent Living, Social Relationships, Family Relationships

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026